Cadila Healthcare Buys Brazilian Pharma Firm

Cadila Healthcare (Ahmedabad, India), a pharmaceuticals company, has signed an agreement to acquire Quimica e Farmaceutica Nikkho do Brasil (Nikkho; Rio de Janeiro), a medium-size pharma company, for about $26 million. The acquisition marks Cadila’s entry into the Brazilian generic pharmaceuticals business. Cadila is acquiring Nikkho through Cadila’s Zydus Healthcare Brasil (Sao Paulo) subsidiary. It is the second overseas acquisition for Cadila this year after the purchase of Nippon Universal Pharmaceutical (Tokyo). Nikkho recorded sales of $26...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers